Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex
- PMID: 402107
- PMCID: PMC351921
- DOI: 10.1128/AAC.11.1.80
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex
Abstract
Serum interferon activity was determined in 12 cynomolgus and 12 rhesus monkeys injected intravenously once daily for 10 days with from 0.1 to 6.0 mg of a stabilized polyriboinosinic acid . polyribocytidylic acid complex per kg, composed of polyriboinosinic acid . polyribocytidylic acid, poly-1-lysine, and carboxymethylcellulose [poly(ICLC)]. Interferon activity was detected 2 h after the first injection, with maximum activity occurring 8 h after the second injection. A period of hyporesponsiveness occurred after the third injection of poly(ICLC) in all monkeys and lasted until the sixth injection in the rhesus monkeys, when interferon activity again became more elevated. The delayed rebound was not as apparent in cynomolgus monkeys. Rhesus monkeys injected with 6 mg/kg did not exhibit serious side effects.
Similar articles
-
Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys.J Infect Dis. 1979 Mar;139(3):267-72. doi: 10.1093/infdis/139.3.267. J Infect Dis. 1979. PMID: 109544
-
Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.Infect Immun. 1981 Nov;34(2):416-21. doi: 10.1128/iai.34.2.416-421.1981. Infect Immun. 1981. PMID: 6171519 Free PMC article.
-
A comparison of interferon responses to poly ICLC in males and females.J Interferon Res. 1992 May;Spec No:85-90. doi: 10.1089/jir.1992.1992.85. J Interferon Res. 1992. PMID: 1379290 Clinical Trial.
-
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates.J Infect Dis. 1975 Oct;132(4):434-9. doi: 10.1093/infdis/132.4.434. J Infect Dis. 1975. PMID: 810520
-
Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.Proc Soc Exp Biol Med. 1982 Feb;169(2):183-8. doi: 10.3181/00379727-169-41329. Proc Soc Exp Biol Med. 1982. PMID: 6174989 No abstract available.
Cited by
-
The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.Antiviral Res. 2015 May;117:75-98. doi: 10.1016/j.antiviral.2015.02.011. Epub 2015 Mar 5. Antiviral Res. 2015. PMID: 25746173 Free PMC article. Review.
-
Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events.Cancers (Basel). 2021 May 7;13(9):2237. doi: 10.3390/cancers13092237. Cancers (Basel). 2021. PMID: 34066908 Free PMC article.
-
Nucleic Acid Immunotherapeutics for Cancer.ACS Appl Bio Mater. 2020 May 18;3(5):2838-2849. doi: 10.1021/acsabm.0c00101. Epub 2020 Mar 16. ACS Appl Bio Mater. 2020. PMID: 33681722 Free PMC article.
-
Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.PLoS One. 2014 Feb 24;9(2):e89735. doi: 10.1371/journal.pone.0089735. eCollection 2014. PLoS One. 2014. PMID: 24586996 Free PMC article.
-
Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.Antimicrob Agents Chemother. 1980 Jan;17(1):49-54. doi: 10.1128/AAC.17.1.49. Antimicrob Agents Chemother. 1980. PMID: 7352750 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources